Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.52 |
| ▸ | CDK4 | P11802 | 4/20 | 0.45 |
| ▸ | CCND1 | P24385 | 4/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6623448 | 0.78 | SLC6A2 (0.49) | SLC6A2CDK4CCND1NOTUMSLC6A4 | |
| SCHEMBL15707807 | 0.77 | SLC6A2 (0.52) | SLC6A2CDK4CCND1NOTUMSLC6A4 | |
| SCHEMBL10826333 | 0.77 | SLC6A2 (0.52) | SLC6A2CDK4CCND1NOTUMMAPK1 | |
| SCHEMBL28444469 | 0.77 | SLC6A2 (0.47) | SLC6A2CDK4CCND1NOTUMSLC6A4 | |
| Hydrochloric Acid SCHEMBL6258187 | 0.77 | SLC6A2 (0.47) | SLC6A2CDK4CCND1NOTUMSLC6A4 | |
| SCHEMBL6628128 | 0.74 | SLC6A2 (0.73) | SLC6A2CDK4CCND1NOTUMSLC6A4 | |
| SCHEMBL3626398 | 0.74 | HTT (0.51) | SLC6A2CDK4CCND1NOTUMMAPK1 | |
| SCHEMBL3976417 | 0.74 | SLC6A2 (0.45) | SLC6A2CDK4CCND1NOTUMSLC6A4 | |
| SCHEMBL10973432 | 0.74 | NOTUM (0.55) | SLC6A2CDK4CCND1NOTUMMAPK1 | |
| SCHEMBL30371592 | 0.74 | NOTUM (0.55) | SLC6A2CDK4CCND1NOTUMMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022000443-A1 | METHODS AND COMPOSITIONS FOR TARGETING TREGS USING CCR8 INHIBITORS | Nanjing Immunophage Biotech Co., Ltd. (CN) | 2022-01-06 | — | — | WO | disclosed |
| EP-2004847-B1 | OLIGONUCLEOTIDES COMPRISING SIGNALLING PAIRS AND HYDROPHOBIC NUCLEOTIDES, STEMLESS BEACONS, FOR DETECTION OF NUCLEIC ACIDS, METHYLATION STATUS AND MUTANTS OF NUCLEIC ACIDS | PENTABASE APS (DK) | 2017-05-03 | — | — | EP | disclosed |
| CN-103664996-A | Indole derivative and preparation method thereof | INST MEDICINAL BIOTECHNOLOGY | 2014-03-26 | — | — | CN | disclosed |
| WO-2011097642-A1 | EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS | TRUSTEES OF BOSTON COLLEGE (US) | 2011-08-11 | — | — | WO | disclosed |
| US-7838669-B2 | Naphthalocyanine dye and method for producing the same | FUJIFILM CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-20070073053-A1 | Naphthalocyanine dye and method for producing the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| EP-1035114-B1 | Processes for the preparation of nitrogen-heterocyclic compounds | TOSOH CORP (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-6346621-B1 | INDOLE OR QUINOLINE COMPOUNDS SUBSTITUTED WITH AMINO COMPOUNDS ON NITROGEN | TOSOH CORPORATION (JP) | 2002-02-12 | — | — | US | disclosed |
| EP-1035114-A2 | Nitrogen-heterocyclic compounds and process for production thereof | TOSOH CORPORATION (JP) | 2000-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070073053-A1 | Naphthalocyanine dye and method for producing the same | RPL41, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NAP1L1 | SLC6A2 592/4885CDK4 3301/4885CCND1 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.